Registry for men receiving TULSA-PRO prostate treatment
Part of Cancer, Kidney & urinary clinical trials.
This is a study registry that collects information from men who are going to receive TULSA-PRO treatment. It helps researchers understand how the treatment is used and what outcomes people experience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male
- You are older than 18 years
- Your doctor has said you are a candidate for TULSA-PRO treatment
- You are willing and able to sign the consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a global registry that collects information about people with an enlarged prostate (BPH) who have urinary symptoms and are receiving treatment. It may help researchers better understand which treatments work best and how symptoms change over time.
This study is a worldwide registry that collects health information from men with advanced prostate cancer. It may help researchers better understand disease patterns and outcomes, which can guide future treatments.
This is a registry study that collects information from men with localized prostate cancer who receive transperineal laser ablation (a procedure done through the skin between the scrotum and anus). It may help doctors better understand outcomes and refine treatment choices over time.
This is a registry study that follows men with low-risk prostate cancer who choose active surveillance instead of immediate treatment. It helps doctors understand how safe and effective active surveillance is, including confirming results with repeat biopsies.
This study is a European registry tracking how a laser treatment (TPLA) helps men with an enlarged prostate and bothersome urinary symptoms. It aims to see how safe and effective this new procedure is for daily life.
This study collects information from men with prostate cancer who are having or have had a procedure to destroy prostate tumors (ablation). It aims to track outcomes over time to improve future treatments.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.